Local anesthetic systemic toxicity (LAST) refers to the complication affecting the central nervous system (CNS) and cardiovascular system (CVS) due to the overdose of local anesthesia. Its reported prevalence is 0.27/1000, and the representative symptoms range from dizziness to unconsciousness in the CNS and from arrhythmias to cardiac arrest in the CVS. Predisposing factors of LAST include extremes of age, pregnancy, renal disease, cardiac disease, hepatic dysfunction, and drug-associated factors. To prevent the LAST, it is necessary to recognize the risk factors for each patient, choose a safe drug and dose of local anesthesia, use vasoconstrictor , confirm aspiration and use incremental injection techniques. According to the treatment guidelines for LAST, immediate application of lipid emulsion plays an important role. Although lipid emulsion is commonly used for parenteral nutrition, it has recently been widely used as a non-specific antidote for various types of drug toxicity, such as LAST treatment. According to the recently published guidelines, 20% lipid emulsion is to be intravenously injected at 1.5 mL/kg. After bolus injection, 15 mL/kg/h of lipid emulsion is to be continuously injected for LAST. However, caution must be observed for >1000 mL of injection, which is the maximum dose. We reviewed the incidence, mechanism, prevention, and treatment guidelines, and a serious complication of LAST occurring due to dental anesthesia. Furthermore, we introduced lipid emulsion that has recently been in the spotlight as the therapeutic strategy for LAST.
INTRODUCTION
An ideal local anesthetics should be potent, reversible, low cost, stable, and easy to metabolize and emit. Furthermore, it should have rapid onset action, suitable duration of effect, and good tissue penetration. Another one of the important qualifications is that there should be no adverse effect, neither local nor systemic. Complications due to local anesthesia can be divided into three major areas; complications associated with vasoconstrictor, needle, and absorption of local anesthetics. Complications associated with the added vasoconstrictor include elevated blood pressure and increased heart rate. Another complications associated with the needle include syncope, hematoma, pain, edema, infection, paresthesia, nerve paralysis, and breakdown of needle or cartridge. Absorption of the local anesthetics include local reaction, idiosyncrasy, toxicity, and allergy or anaphylactic reaction [1] . In this article, we have focused on local anesthetic systemic toxicity (LAST), which refers to systemic toxicity rather than local reactions due to local anesthetics, and the usage of lipid emulsion for treatment of LAST. Lipid emulsion is mainly used as parenteral nutrition for patients in intensive care units, but it has recently been widely used as a non-specific antidote in various types of drug toxicity, including that of local anesthesia [2] .
Paul et al. have described the toxicity caused by overdose of local anesthetics during dental treatments and the pharmacokinetic progression, and reported the importance of drug selection and safety levels of the drugs [3] . For the first time, Ciechanowicz et al. reviewed the use of lipid emulsion in the treatment of LAST and its effect in dentistry [4] . In this study, we aimed to review the predisposing factors of LAST in dentistry and present the effectiveness and mechanism of lipid emulsion as per the guidelines of this treatment.
SYSTEMIC TOXICITY OF DENTAL ANESTHESIA
Incidence and etiology
LAST refers to the complication particularly affecting the central nervous system (CNS) and cardiovascular system (CVS) due to the overdose of local anesthetics [5] [6] [7] [8] . LAST is a life-threatening complication and reportedly occurs in 0.03% people (0.27/1,000) [9] [10] [11] .
To elaborate, the order of incidence of complications from highest to lowest based on the type of block is penile, local infiltration, neuraxial, upper extremity, paravertebral, lower extremity, head and neck, topical, transversus abdominis plane, and intravenous block.
Penile blocks are most commonly associated with complications, because of the large distribution of blood vessels [12] . This is followed by local infiltration, which is commonly used in dentistry. The order of incidence of complications from highest to lowest according to the local anesthetics used is bupivacaine, lidocaine, ropivacaine, mixture local anesthetics, levobupivacaine, chloroprocaine, and articaine. Lidocaine, the most commonly used anesthetic in dentistry, accounted for approximately 25% of complications reported. The high incidence of complications of lidocaine, which is comparative safe, could be due to its high frequency of use [13] [14] [15] [16] [17] . If the local anesthetics has been mainly injected directly into the blood vessel, LAST appears immediately after injection; whereas, if the anesthetic is absorbed from the blood vessels into the tissues, LAST appears over time after injection [18] [19] [20] [21] .
Symptoms and signs
LAST is a fatal complication caused by overdose of local anesthesia; therefore, when symptoms occur, it should be recognized immediately. The American Society of Anesthesiologists recommends standard monitoring (electrocardiogram, blood pressure, oxygen saturation) for immediate recognition. It is helpful to talk to the patient often and check for symptoms indicating LAST [22] . The symptoms of fatal LAST occurring due to local anesthesia in dentistry can be divided into the CNS symptoms and CVS symptoms (Table 1 ) [4] .
Because of the wide spectrum of symptoms related to the CNS, the adverse effects can be recognized quickly. and continued monitoring is necessary [32, 33] .
Predisposing factors
There are two predisposing factors for LAST: patient factors and drug factors. Patient factors include age, weight, consuming other medicines simultaneously, presence of other diseases, genetic factors, and mental status. Therefore, recording medical history before local anesthesia administration is required. It may be helpful to have the questionnaire written before the treatment and using it to collect the necessary information.
Some view age as the biggest risk factor in LAST [11] .
Because neonates and infants have small number of enzymes decomposing local anesthetics, 15% reduced dose is injected in young infants <4 months old. In elderly patients, drug accumulation increases due to the decrease in the metabolic organ perfusion and pharmacodynamic functions. Moreover, because of the reduction of skeletal muscle mass, which is a reservoir of local anesthetics, the risk of LAST increases in older patients. Thus, it is recommended to use 10-20% reduced doses of the recommended dose [34] . In pregnant patients, high Hence, uptake is easy and the risk of LAST increases.
Therefore, most dental local anesthetics are used along with a vasoconstrictor to decrease complications and increase duration. The blood concentration of local anesthetics influences the occurrence of LAST. There is a high tendency for LAST to occur if the local anesthetics are injected directly into the blood vessels, the injected dosage is high, the drug is fast absorbing, or the drug slows metabolism or excretion. Moreover, local anesthetics with high lipid solubility (e.g., bupivacaine)
usually cause cardiovascular collapse more commonly than local anesthetics with low lipid solubility (e.g., lidocaine). Cardiac arrest due to bupivacaine toxicity, which is the most lethal toxicity due to local anesthetics, does not respond to cardiopulmonary resuscitation (CPR) [42] .
Prevention
To prevent LAST, appropriate plasma concentration of local anesthetics is important, and hence the safe dosage of each local anesthetics should be known along with the risk factors of each patient must be assessed before injecting the appropriate dose (Table 2) . Although the threshold of plasma concentration may differ in each patient [43] , the doses in normal patients and in those with risk factors must be differentiated.
The dentists must also select the appropriate drug carefully. Because highly lipid-soluble bupivacaine has a tendency to induce a cardiovascular collapse [42] , it must be used cautiously where other drugs cannot be used (e.g., lidocaine allergy). As levobupivacaine and ropivacaine show similar pharmacokinetics as bupivacaine, the safe dosage must be noted (2.0 mg/kg for bupivacaine, The revisions made in the second update in 2012 [38] and the third update in 2018 [27] 
Mechanism of lipid emulsion
Rosenblatt et al. [44] reported a case of successful recovery in a patient with cardiac arrest caused by LAST due to bupivacaine and mepivacaine, who was treated by injecting 20% lipid emulsion while performing CPR.
Since then, many cases of LAST treated using lipid emulsion as an antidote have been reported [11] .
There are several mechanisms of lipid emulsion presented. The "lipid sink" hypothesis, which claims that the drugs with high lipid-solubility are pulled from the tissue into the lipid emulsion, and the "metabolic effect"
hypothesis, which claims that lipid emulsion reverses the local anesthetics' inhibition of the fatty acid oxidation in the heart, are two of the most widely accepted hypotheses [45, 46] . Evidence supporting the lipid sink hypothesis includes the fact that lipid emulsion absorbs more of the drug from the tissue to reverse its effect if the drug has higher lipid solubility, and that bupivacaine, which has higher lipid solubility than other local anesthetics, responds well to lipid emulsion therapy [45, 47] . Furthermore, the reports that lipid emulsion is effective for treating toxicity caused not only by local anesthetics, but also by propranolol, verapamil, and amitriptyline could be related to the high lipid-solubility of these drugs [48, 49] . Metabolic effect asserts that the lipid emulsion itself has cardiac contraction-promoting and metabolic effects. Bupivacaine inhibits fatty acid oxidation by suppressing the acylcarnitine exchange that is necessary for fatty oxidation to provide energy to the heart.
Intralipid recovers fatty acid oxidation in the heart to recover from cardiac arrest due to toxic concentration [50] [51] [52] . These results could explain the mechanism of directly treating toxicity caused by local anesthetics, rather than the indirect function of the lipid sink [46, 53] .
CONCLUSION: LAST, LIPID EMULSION, AND DENTAL ANESTHETICS
Although the cases of LAST caused by dental local anesthesia are rare, it can be a serious problem if appropriate steps are not taken. There are no statistical data on the frequency of LAST in dentistry yet. However, the risk of intravenous injection during the commonly performed inferior alveolar nerve block is relatively high (15.3%), and so is the subsequent risk of LAST due to this [54] . The frequency of the use of high-potency, ester-type local anesthetics like bupivacaine in dentistry is not high. Even among the amide-types, only lidocaine is commonly used, and the potency is not high [3] . The risk of LAST still exists even if amide-type anesthetics are used, and the risk is higher if amide-types cannot be used (e.g., lidocaine allergy).
Dentists who perform block anesthesia multiple times a day must be cognizant of the treatments for LAST in case of its occurrence. Fortunately, significant progress has been made after the introduction of lipid emulsion as an effective treatment for LAST. If a LAST event occur, the dentists should be accurately known about fast recognition, use of lipid emulsion depending on the situation, and follow-up to avoid catastrophic events during dental treatments.
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